Atezolizumab Trial in Endometrial Cancer - AtTEnd
Clinical trial NCT03603184 · COMPLETED
Trial details
- NCT number
- NCT03603184
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-02
- Primary completion
- 2025-01-20
- Enrollment
- 549
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.